[Isolation rate and susceptibilities of Candida species from blood, vascular catheter, urine and stool].
We evaluated species distribution and antifungal susceptibility of Candida isolates during 2002-2008. Of 177 Candida isolates from blood, species distribution was 90 (51%) Candida albicans, 30 (17%) C. parapsilosis, 22 (12%) C. glabrata, 6 (3%) C. tropicalis and 29 (16%) other Candida spp.. Of 162 Candida isolates from vascular catheter, species distribution was 87 (54%) C. albicans, 14 (9%) C. parapsilosis, 36 (22%) C. glabrata, 5 (3%), C. tropicalis, 2 (1%) C. krusei and 18 (11%) other Candida spp.. Of 1889 Candida isolates from urine, species distribution was 1165 (62%) C. albicans, 22 (1%) C. parapsilosis, 484 (26%) C. glabrata, 83 (4%) C. tropicalis, 26 (1%) C. krusei and 109 (6%) other Candida spp.. Of 782 Candida isolates from stool, species distribution was 425 (54%) C. albicans, 3 (1%) C. parapsilosis, 103 (13%) C. glabrata, 28 (4%) C. tropicalis, 5 (1%), C. krusei and 218 (28%) other Candida spp.. Both C. albicans and non-Candida spp. isolated from urine increased slightly over the past 7 years. Flucytosine, fluconazole, itraconazole and micafungin still have strong activity against Candida isolates.
Tashiro
Masato
M
Department of Microbiology, Toho University School of Medicine.
Murakami
Hinako
H
Yoshizawa
Sadako
S
Tateda
Kazuhiro
K
Yamaguchi
Keizo
K
D001769:Blood / Q000382:microbiology; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification*; D002408:Catheters, Indwelling / Q000382:microbiology*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D014556:Urine / Q000382:microbiology*